Stocks and Investing
Stocks and Investing
Thu, August 22, 2024
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
[ Thu, Aug 22nd 2024
] - WOPRAI
Joanna Wiensch Maintained (ABT) at Strong Buy with Increased Target to $127 on, Aug 22nd, 2024
Joanna Wiensch of Citigroup, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Increased Target from $119 to $127 on, Aug 22nd, 2024.
Joanna has made no other calls on ABT in the last 4 months.
There are 4 other peers that have a rating on ABT. Out of the 4 peers that are also analyzing ABT, 0 agree with Joanna's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Joanna
- Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $143 on, Monday, July 29th, 2024
- Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Decreased Target to $120 on, Tuesday, July 2nd, 2024
- Shagun Singh of "RBC Capital" Reiterated at Buy and Held Target at $125 on, Tuesday, June 4th, 2024
- David Roman of "Goldman Sachs" Initiated at Strong Buy and Held Target at $121 on, Thursday, May 30th, 2024
Contributing Sources